54 results
S-3
EX-4.3
LCTX
Lineage Cell Therapeutics Inc
Shelf registration
7 Mar 24
5:17pm
S-3
EX-4.3
LCTX
Lineage Cell Therapeutics Inc
Shelf registration
11 Mar 21
4:53pm
S-3
EX-4.6
LCTX
Lineage Cell Therapeutics Inc
Shelf registration
11 Mar 21
4:53pm
S-3
EX-4.7
LCTX
Lineage Cell Therapeutics Inc
Shelf registration
11 Mar 21
4:53pm
S-3
EX-4.5
LCTX
Lineage Cell Therapeutics Inc
Shelf registration
11 Mar 21
4:53pm
S-8
EX-4.2
igewjw0wo55d2by430u
7 Jul 17
Registration of securities for employees
12:00am
8-K
EX-10.3
woztukig
29 Aug 16
Entry into a Material Definitive Agreement
12:00am
S-8
EX-4.1
f11h6 zispmu44x5
15 Jul 15
Registration of securities for employees
12:00am
8-K
EX-4.1
x4w1k
23 Sep 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.1
35np4j0
5 Mar 14
Entry into a Material Definitive Agreement
12:00am
POS AM
EX-4.3
jkivj5f3
17 Dec 13
Prospectus update (post-effective amendment)
12:00am
8-K
EX-4.1
zpcs bhko
1 Oct 13
Asterias Biotherapeutics, Inc., a Subsidiary of BioTime, Inc., Acquires Geron’s Embryonic Stem Cell Assets
12:00am
8-K
EX-4.1
x7bxhyezbs klt9v33
3 Jun 13
BioTime, Inc. to Raise $9 Million in Registered Direct Offering
12:00am